ITM2C (N-term), 27-55 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-ITM2C (N-term), 27-55 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityITM2C (N-term), 27-55
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman (predicted reactivity: monkey)
Isotypen/a
Formatpeptide affinity purified
Size0.08 mL, 0.4 mL
Concentrationvial concentration: 0.36
ApplicationsWestern Blot (WB), ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis ITM2C antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 27-55 amino acids from the N-terminal region of human ITM2C. Negative regulator of beta amyloid peptide production. May inhibit the processing of APP by blocking its access to alpha-and beta-secretase. Binding to the beta-secretase-cleaved APP C-terminal fragment is negligible, suggesting that ITM2C is a poor gamma-secretase cleavage inhibitor. May play a role in TNF-induced cell death and neuronal differentiation (By similarity).
Immunogenn/a
Other Names[Integral membrane protein 2C; Cerebral protein 14; Transmembrane protein BRI3; CT-BRI3; ITM2C; BRI3]
Gene, Accession #[ITM2C], Gene ID: 81618, NCBI: NP_001012532.1, UniProt: Q9NQX7
Catalog #MBS9201371
Price$165, $370
Order / More InfoITM2C (N-term), 27-55 Antibody from MYBIOSOURCE INC.
Product Specific ReferencesYoshida, T., et al. Int. J. Mol. Med. 25(4):649-656(2010) Oguri, M., et al. Am. J. Hypertens. 23(1):70-77(2010) Matsuda, S., et al. J. Biol. Chem. 284(23):15815-15825(2009) Matsuda, S., et al. Mol Neurodegener 4, 41 (2009) : Gong, Y., et al. BMB Rep 41(4):287-293(2008)
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.